| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.43 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.36 | 0.07 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.01 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.3 | 0.05 |